arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

LeonaBio, Inc.

LONA

$7.77 ▼ -0.22 (-2.75%) at close

8 Visible periods

19 Metrics

Absolute Benchmarks

Price Chart

Health

Poor

Bearish Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, LeonaBio, Inc. shows weak fundamentals, weighed down by Return on Invested Capital and FCF / Net Income. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $33.2M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -290.7% ↘

FCF / Share $-10.69 ↗

Trailing P/E —

Price / Book 2.6x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

8-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-105.61M

↓ -8.9% —

FCF / Share Free cash flow per share

$-10.69

↑ +57.7% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Invested CapitalReturn on Invested Capital of -290.7% is weak on an absolute basis (target > 10%)
FCF / Net IncomeFCF / Net Income of 0.43x is weak on an absolute basis (target > 1x)

Health Breakdown

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
EPS Growth YoY (%)	1.9% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	18.5% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	-22.1% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-69.8% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—
Net Income Growth YoY (%)	-8.9% Weak ↑ Weak Improving Year-over-year change in net income	17.6% Good ↑ Good Improving Year-over-year change in net income	-23.0% Weak ↑ Weak Improving Year-over-year change in net income	-74.4% Weak ↑ Weak Improving Year-over-year change in net income	-174.9% Weak Weak Year-over-year change in net income	-286.6% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	57.7% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	5.0% Caution ↑ Caution Improving Year-over-year change in free cash flow	-36.3% Weak Weak Year-over-year change in free cash flow	-61.2% Weak Weak Year-over-year change in free cash flow	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
FCF / Net Income (x)	0.43x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.00x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.32x Good Good Free cash flow relative to reported net income Optimal: > 1x	0.72x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Return on Invested Capital (%)	-290.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-177.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-76.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-34.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.8% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	21.8% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-111.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-171.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-78.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-40.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-19.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-7.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-248.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	—	-216.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1541%)	-90.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-703%)	-40.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-371%)	-17.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-214%)	-7.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-149%)	26.2% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+74%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Interest Coverage (x)	—	—	—	—	—	-54.48x Weak Weak Operating income divided by interest expense Optimal: > 5x	-15.75x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-69.28M	$-48.44M	$-90.58M	$-95.97M	$-110.54M	$-60.62M	$-2.06M	—

📊 What does each share earn? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Basic EPS, GAAP (USD)	$-24.70	$-25.19	$-30.90	$-25.30	$-14.90	—	—	—
Free Cash Flow per Share (USD)	$-10.69	$-25.26	$-26.58	$-19.51	$-12.10	—	—	—
Book Value per Share (USD)	$2.98	$11.49	$34.11	$62.08	$85.90	$84.43	$-54.16	—
Tangible Book Value per Share (USD)	$2.98	$11.49	$34.11	$62.08	$85.90	$84.43	$-54.16	—
Basic Weighted Avg Shares (shares)	4.28M	3.85M	3.80M	3.77M	3.69M	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Working Capital (USD)	$41.95M	$41.71M	$125.89M	$186.10M	$251.51M	$187.93M	$887.00K	—
Total Equity (USD)	$27.79M	$44.84M	$130.19M	$235.14M	$321.08M	$274.28M	$-19.72M	$-14.89M

📋 What is driving earnings? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗
Depreciation Expense (USD)	$972.00K	$970.00K	$969.00K	$845.00K	$479.00K	$2.00K	$2.00K	—
Net Income, GAAP (USD)	$-105.61M	$-96.94M	$-117.67M	$-95.64M	$-54.85M	$-19.95M	$-5.16M	—
Operating Cash Flow (USD)	$-45.73M	$-97.17M	$-100.75M	$-72.47M	$-43.10M	$-24.11M	$-3.71M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 8 years · 29 quarters

LeonaBio, Inc.

Analytical Summary

8-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare LONA with peers